Arecor Establishes Partnership With Biopharmaceutical Company to Develop Novel Formulation of Peptide Therapy
Arecor Therapeutics plc
(“Arecor” or the “Company”)
ARECOR ESTABLISHES PARTNERSHIP WITH BIOPHARMACEUTICAL COMPANY TO DEVELOP NOVEL FORMULATION OF PEPTIDE THERAPY
- Partner to fund development work with option to acquire rights to proprietary formulation under Arecor’s technology licensing model